Intensive Reinduction Chemotherapy Followed by Early Allogeneic Hematopoietic Cell Transplantation for Relapsed/Refractory High-Grade Myeloid Neoplasms.
Saved in:
| Title: | Intensive Reinduction Chemotherapy Followed by Early Allogeneic Hematopoietic Cell Transplantation for Relapsed/Refractory High-Grade Myeloid Neoplasms. |
|---|---|
| Authors: | Kopmar NE; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington., Othus M; Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington., Quach K; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington., Rasmussen A; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington., Schonhoff K; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington., Becker PS; City of Hope Cancer Center, Duarte, California., Walter RB; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington; Department of Epidemiology, University of Washington, Seattle, Washington., Halpern AB; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington., Salit R; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington., Cassaday RD; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington., Shustov A; Cellectar Biosciences, Florham Park, New Jersey., Stewart FM; City of Hope Cancer Center, Duarte, California., Oehler VG; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington., Scott BL; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington., Sandmaier BM; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington., Lee SJ; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington., Estey EH; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington., Percival MM; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington. Electronic address: mperciva@uw.edu. |
| Source: | Transplantation and cellular therapy [Transplant Cell Ther] 2024 Jul; Vol. 30 (7), pp. 727.e1-727.e8. Date of Electronic Publication: 2024 May 05. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38710302 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Intensive Reinduction Chemotherapy Followed by Early Allogeneic Hematopoietic Cell Transplantation for Relapsed/Refractory High-Grade Myeloid Neoplasms. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kopmar+NE%22">Kopmar NE</searchLink>; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Othus+M%22">Othus M</searchLink>; Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Quach+K%22">Quach K</searchLink>; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Rasmussen+A%22">Rasmussen A</searchLink>; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Schonhoff+K%22">Schonhoff K</searchLink>; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Becker+PS%22">Becker PS</searchLink>; City of Hope Cancer Center, Duarte, California.<br /><searchLink fieldCode="AU" term="%22Walter+RB%22">Walter RB</searchLink>; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington; Department of Epidemiology, University of Washington, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Halpern+AB%22">Halpern AB</searchLink>; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Salit+R%22">Salit R</searchLink>; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Cassaday+RD%22">Cassaday RD</searchLink>; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Shustov+A%22">Shustov A</searchLink>; Cellectar Biosciences, Florham Park, New Jersey.<br /><searchLink fieldCode="AU" term="%22Stewart+FM%22">Stewart FM</searchLink>; City of Hope Cancer Center, Duarte, California.<br /><searchLink fieldCode="AU" term="%22Oehler+VG%22">Oehler VG</searchLink>; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Scott+BL%22">Scott BL</searchLink>; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Sandmaier+BM%22">Sandmaier BM</searchLink>; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Lee+SJ%22">Lee SJ</searchLink>; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Estey+EH%22">Estey EH</searchLink>; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Percival+MM%22">Percival MM</searchLink>; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington. Electronic address: mperciva@uw.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101774629%22">Transplantation and cellular therapy</searchLink> [Transplant Cell Ther] 2024 Jul; Vol. 30 (7), pp. 727.e1-727.e8. <i>Date of Electronic Publication: </i>2024 May 05. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Inc%22">Elsevier Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101774629 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2666-6367 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226666367%22">26666367 </searchLink><i>NLM ISO Abbreviation: </i>Transplant Cell Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38710302 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jtct.2024.05.002 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 727.e1-727.e8 Titles: – TitleFull: Intensive Reinduction Chemotherapy Followed by Early Allogeneic Hematopoietic Cell Transplantation for Relapsed/Refractory High-Grade Myeloid Neoplasms. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kopmar NE – PersonEntity: Name: NameFull: Othus M – PersonEntity: Name: NameFull: Quach K – PersonEntity: Name: NameFull: Rasmussen A – PersonEntity: Name: NameFull: Schonhoff K – PersonEntity: Name: NameFull: Becker PS – PersonEntity: Name: NameFull: Walter RB – PersonEntity: Name: NameFull: Halpern AB – PersonEntity: Name: NameFull: Salit R – PersonEntity: Name: NameFull: Cassaday RD – PersonEntity: Name: NameFull: Shustov A – PersonEntity: Name: NameFull: Stewart FM – PersonEntity: Name: NameFull: Oehler VG – PersonEntity: Name: NameFull: Scott BL – PersonEntity: Name: NameFull: Sandmaier BM – PersonEntity: Name: NameFull: Lee SJ – PersonEntity: Name: NameFull: Estey EH – PersonEntity: Name: NameFull: Percival MM IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2024 Jul Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2666-6367 Numbering: – Type: volume Value: 30 – Type: issue Value: 7 Titles: – TitleFull: Transplantation and cellular therapy Type: main |
| ResultId | 1 |
